Sanofi India Ltd

As of 24-Nov, Sanofi India Ltd’s stock price has fallen sharply, reflecting persistent challenges in sales growth and sustained underperformance relative to market benchmarks.

Yes, Sanofi India Ltd has declared a dividend of 750% (₹117 per share) with an ex-date of November 7, 2025. Despite the dividend, the company's stock has shown negative total returns across various periods, indicating challenges in performance.

Sanofi India's historical performance for the fiscal years ending December 2023 and 2024 shows slight growth in net sales and operating income, but declines in profitability metrics, including net profit and earnings per share. Total liabilities and assets also decreased, while cash flow from operations improved.

Sanofi India's latest Q2 FY26 results show a slight decline in net sales but a year-on-year growth, with net profit down significantly by 45.89%. While the company maintains strong capital efficiency and stable operating margins, the drop in profitability and ongoing revenue challenges indicate areas of concern for investors.

Sanofi India will announce its results on 29 October 2025.

As of 29-Sep, Sanofi India Ltd's stock price is at 4,709.00, down 0.87% and has declined 6.95% over the last eight days. The stock has underperformed significantly over the past year with a return of -30.75%, amid challenges in net sales and profit, despite strong management efficiency.

As of 24-Sep, Sanofi India Ltd's stock price is 4,994.30, down 0.21% and has declined 1.31% over the past week. The stock has underperformed significantly over the year, with an 18.12% drop year-to-date, amidst disappointing financial results and a lack of investor confidence.

As of 23-Sep, Sanofi India Ltd's stock price is declining at 5,000.00, down -0.28%, and has lost value for four consecutive days. The stock is trading below all major moving averages and has significantly underperformed the market, with a year-to-date return of -18.03% and a one-year return of -30.70%, indicating bearish sentiment and lack of investor confidence.

As of 22-Sep, Sanofi India Ltd's stock price is at 5,020.00, down 0.31% and has declined 30.22% over the past year. The stock has underperformed compared to the Sensex and shows weak long-term growth prospects due to declining sales and profitability.

As of 19-Sep, Sanofi India Ltd's stock price is declining at 5,038.65, down 0.11%, and has underperformed its sector. The stock shows a bearish trend with significant declines in profits and poor long-term growth prospects, leading to a negative outlook.

As of 18-Sep, Sanofi India Ltd's stock price is 5,043.95, down 0.33%, and has significantly underperformed its sector and the broader market. Despite strong management efficiency, the stock faces challenges due to declining sales and profits, leading to a negative outlook.

As of 17-Sep, Sanofi India Ltd's stock price is at 5,060.75, showing a slight increase today but a significant year-to-date decline of 17.03%. Despite strong management efficiency indicators, the stock's long-term growth prospects are concerning due to declining profits and underperformance relative to the broader market.

As of 16-Sep, Sanofi India Ltd's stock price is 5,029.45, down 0.22%, and has underperformed its sector. Despite strong management efficiency, the stock has seen a significant annual decline of -30.10% and negative sentiment due to recent poor financial results.

As of 15-Sep, Sanofi India Ltd's stock price is 5,040.50, down 0.57%, and has shown a year-to-date decline of 17.36%. The stock is trading below all major moving averages, indicating bearish momentum and underperformance compared to the benchmark Sensex.

As of 12-Sep, Sanofi India Ltd's stock price is at 5,069.50, down 0.13%, and has underperformed its sector. The stock shows a bearish trend, with a significant annual decline of -29.73% and concerning financials, leading to a cautious outlook among investors.

As of 11-Sep, Sanofi India Ltd's stock price is 5,076.00, with a slight increase of 0.1% over the last two days. Despite this, the stock has underperformed its sector and benchmark, showing significant declines over the past week, month, and year, alongside decreasing investor participation and challenging long-term growth prospects.

As of 10-Sep, Sanofi India Ltd's stock price is at 5,070.95, having increased by 0.61% after a decline, but it has underperformed over the past year with a return of -30.96%. Despite high management efficiency and institutional holdings, negative growth in sales and profits raises concerns about its long-term viability.